Efficacy and safety of intravenous nerinetide in acute ischemic stroke patients undergoing endovascular thrombectomy without thrombolysis: a meta-analysis of randomized controlled trials.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Neuroradiology

• Publication date

  2025-12-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00234-025-03847-zPMID 41400652PMCID PMC13021738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study.

  2025cited by this paper
• Factors Influencing Nerinetide Effect on Clinical Outcome in Patients Without Alteplase Treatment in the ESCAPE-NA1 Trial

  2025cited by this paper
• Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial.

  2025cited by this paper
• Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

  2020cited by this paper
• RoB 2: a revised tool for assessing risk of bias in randomised trials

  2019cited by this paper
• Efficacy of the PSD95 inhibitor Tat-NR2B9c in mice requires dose translation between species

  2016cited by this paper
• Rayyan—a web and mobile app for systematic reviews

  2016cited by this paper
• Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain

  2012cited by this paper
• Neuroprotection by Freezing Ischemic Penumbra Evolution Without Cerebral Blood Flow Augmentation With a Postsynaptic Density-95 Protein Inhibitor

  2011cited by this paper
• Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis.

  2010cited by this paper
• Effectiveness of PSD95 Inhibitors in Permanent and Transient Focal Ischemia in the Rat

  2008cited by this paper
• Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions

  2002cited by this paper

• No citing papers are available for this paper.